ReviewFrontiers in digital health2026
Large language models in healthcare quality management: a European perspective on process automation and compliance.
Review in Frontiers in digital health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Artificial Intelligence in Pharmaceutical Regulatory Science: Opportunities, Challenges, and Emerging Frameworks.The AAPS journal · 2026Review
- Local Deployment of Open-Weight Language Models in Dermatology: Viewpoint on Privacy, Equity, and Practical Implementation.JMIR dermatology · 2026Article
- Hotspot Evolution and Future Prospects of Large Language Models in Medical Education: A Bibliometric Analysis.Advances in medical education and practice · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Large Language Models (LLMs) are transforming back-office quality management processes in European healthcare systems through automation of compliance monitoring, quality assurance, and process optimization without direct patient interaction. This narrative review synthesizes evidence from recent systematic reviews and implementation studies (2023-2025) examining LLM deployment within the European regulatory framework encompassing the Medical Device Regulation (MDR), General Data Protection Regulation (GDPR), and the EU Artificial Intelligence Act (Regulation EU 2024/1689). Current research demonstrates meaningful efficiency gains: individual studies of AI-assisted documentation tools report improvements ranging from modest increases in documentation speed to reductions in processing time approaching 50%, while broader policy analyses estimate administrative workload reductions of up to 30% through digital health and AI solutions. Clinical trial applications show particular maturity, with LLM-generated informed consent forms demonstrating improved readability (76% vs. 67%) without compromising accuracy. However, critical gaps persist between research achievements and practical deployment. Analysis of 519 evaluation studies reveals that only 5% utilized real patient care data, while 95% focused exclusively on accuracy metrics to the neglect of fairness (16%), deployment readiness (5%), and calibration (1%). No LLM-based quality management system has yet received regulatory clearance, and implementation science frameworks remain underdeveloped. We propose a risk-stratified implementation framework emphasizing process-oriented applications-standard operating procedure automation, audit documentation, deviation management, and compliance monitoring-that avoid medical device classification while capturing substantial operational benefits. Advanced methodological approaches including retrieval-augmented generation (RAG) architectures, digital twin integration, and natural language processing-based pattern recognition offer pathways toward comprehensive quality intelligence platforms. The convergence of LLMs with emerging technologies such as knowledge graphs, digital twin architectures and multimodal analysis creates opportunities for predictive quality management that anticipates rather than merely documents quality-relevant events. Evidence supports deployment in administrative quality processes, with particular potential for applications that redirect human expertise from documentation toward quality improvement activities, though current evidence derives predominantly from non-European healthcare contexts and simulated or limited-scope settings. Success requires adapted validation methodologies addressing LLM non-determinism, robust governance structures, and comprehensive change management that maintains the high standards European healthcare systems demand.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.